Per‐Anders Jansson

Inhibition of Dipeptidyl Peptidase-4 Reduces Glycemia, Sustains Insulin Levels, and Reduces Glucagon Levels in Type 2 Diabetes

Bo Åhrén, Mona Landin‐Olsson, Per‐Anders Jansson et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 711 citations

Glucagon Responses, Glycobiology, Insulin Signaling +18

A microdialysis method allowing characterization of intercellular water space in humans

Peter Lönnroth, Per‐Anders Jansson, Ulf Smith · American Journal of Physiology-Endocrinology and Metabolism · 1987 · 631 citations

Engineering, Healthy Subjects, Electrodialysis +21

Inhibition of Dipeptidyl Peptidase IV Improves Metabolic Control Over a 4-Week Study Period in Type 2 Diabetes

Bo Åhrén, Erik Simonsson, Hillevi Larsson et al. · Diabetes Care · 2002 · 423 citations · Full text

Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study

Jan W. Eriksson, Per Lundkvist, Per‐Anders Jansson et al. · Diabetologia · 2018 · 368 citations · Full text

Impact of age, BMI and HbA1c levels on the genome-wide DNA methylation and mRNA expression patterns in human adipose tissue and identification of epigenetic biomarkers in blood

Tina Rönn, P. Volkov, Linn Gillberg et al. · Human Molecular Genetics · 2015 · 270 citations